CDNA
Diagnostics & Research · Healthcare
CFO
Equibles does not estimate personal net worth.
Marcel Konrad was last confirmed as CFO at CareDx, Inc. (CDNA) in a filing dated May 2, 2022. The proxy statement of CareDx, Inc. reports total compensation of $679,892 for Marcel Konrad in fiscal 2021, including a base salary of $160,478. Disclosed compensation is on record for 2 fiscal years. Marcel Konrad has spoken on 1 earnings call across 1 company, most recently for CareDx, Inc. on February 24, 2021. The companies whose calls Marcel Konrad spoke on are classified in the Healthcare sector.
“Turning first to the income statement, our fourth quarter of 2020 testing service revenue increased 73% year-over-year to $50.3 million. The growth in the fourth quarter testing services revenue was driven by AlloSure Kidney and AlloMap Heart patient results.”
Start not stated–2022-05-02
Last confirmed by a filing; no departure on record
CDNA
Diagnostics & Research · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | CareDx, Inc. (CDNA) | Former Interim Chief Financial Officer | $160,478 | $679,892 |
| 2020 | CareDx, Inc. (CDNA) | Former Interim Chief Financial Officer | $283,659 | $953,469 |